Transgenomic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary Marketline’s Transgenomic, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Transgenomic, Inc. since January 2007.
Synopsis Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights This report includes Transgenomic, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Transgenomic, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope - Provides intelligence on Transgenomic, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions. - Detailed reports of various financial transactions undertaken by Transgenomic, Inc. and its subsidiaries since 2007. - Information about key financial and legal advisors for Transgenomic, Inc.’s financial deals transactions. - Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy - Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. - Form an independent opinion about Transgenomic, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. - Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
249 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...
Gene therapy: More than half of industry revenue is generated by sales of healthcare products Abstract Biotechnology in the US The Biotechnology industry is growing quickly, characterized by a multitude of product applications and a wide range of burgeoning markets. Growing demand for ethanol indicates...
The Smart Label Market is expected to grow at a CAGR of 13.2% over the forecast period (2021-2026). Smart labels are becoming one of the most popular technologies across the retail, healthcare, and logistics sectors, and are viewed as an ideal means to achieve greater efficiencies and profitability while providing the authenticity of an item...
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
Hypoglycemia - Pipeline Review, H2 2020
This latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia - Pipeline Review, H2 2020, provides an overview of the Hypoglycemia (Metabolic Disorders) pipeline landscape.
Hypoglycemia is a condition characterized by an...
Hypoglycemia - Pipeline Review, H1 2020
The latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia - Pipeline Review, H1 2020, provides an overview of the Hypoglycemia (Metabolic Disorders) pipeline landscape.
Hypoglycemia is a condition characterized by an abnormally...
Toxoplasmosis - Pipeline Review, H2 2019
This latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Pipeline Review, H2 2019, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape.
Toxoplasmosis is a disease that results from infection...
Summary Noxxon Pharma AG (Noxxon) is a clinical stage biotechnology company that develops and provides drugs for the treatment of cancer.The company develops therapeutics for the treatment of inflammatory diseases and hematological disorders, diabetes and renal diseases, oncology, inflammation and pain. Its pipeline...
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.